ENDPOINTS

Illumina to buy SomaLogic for $350M upfront, pushing further into proteomics

Illumina has agreed to pay $350 million upfront for SomaLogic, the companies announced on Monday, in a deal that underscores the DNA giant's strategy of offering a broader look at biology. SomaLogic specializes in proteomics ...

Jun 23, 2025 - 15:10
 0
Illumina to buy SomaLogic for $350M upfront, pushing further into proteomics
Illumina has agreed to pay $350 million upfront for SomaLogic, the companies announced on Monday, in a deal that underscores the DNA giant's strategy of offering a broader look at biology. SomaLogic specializes in proteomics ...
Read More

Tags:

Previous Article

Obesity drugs show promise treating a new ailment: migraine

Next Article

Clean-energy transition sees a rebound – and more top energy stories

Related Posts

Incyte’s promising thrombocythemia drug; Crescent Biopharma raises $200M in PIPE

Incyte’s promising thrombocythemia drug; Crescent Bioph...

Jun 16, 2025  0

Actio gets $66M for experimental epilepsy and Charcot-Marie-Tooth treatments

Actio gets $66M for experimental epilepsy and Charcot-M...

Jun 18, 2025  0

TIGIT graveyard expands as GSK drops late-stage asset with iTeos

TIGIT graveyard expands as GSK drops late-stage asset w...

May 13, 2025  0